DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up

• click to rate

  Posted by Two Blokes Apr 16 - Filed in Stock - 3 views
  
  Precision BioSciences stock soars 24% as the FDA grants the Fast Track designation to its PBGENE-HBV gene therapy for potentially curing chronic hepatitis B.